PA-BOOMI
Boomi™, the intelligent integration and automation leader, is proud to announce that it has been granted two new patents by the United States Patent and Trademark Office (USPTO) in the field of Artificial Intelligence (AI). These patents boost Boomi's total patent number to 36, underscoring the company's commitment to innovation and its ongoing efforts to push the boundaries of AI advancement.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240131961796/en/
Boomi Secures Two Patents for AI Innovation (Graphic: Business Wire)
The newly granted U.S. Patent No. 11,886,965, titled “Artificial-Intelligence-Assisted Construction of Integration Processes,” encompasses the underlying technology of features that allow Boomi’s customers to build integrations based on Boomi suggestions, including Shape Suggest, Quick Start, and more recently, Boomi AI. This innovation addresses the steep learning curve that users, both novice and expert, face when constructing integration processes on an integration platform.
Employing machine learning models – based on a Markov chain or various forms of graph neural networks – facilitates a predictive guidance system for users, enhancing the efficiency and effectiveness of constructing integration processes.
“Our patent award for ‘Artificial-Intelligence-Assisted Construction of Integration Processes’ stands as a notable innovation in the domain of integration platform as a service (iPaaS), and is a testament to the hard work and dedication of our talented team of engineers, scientists, and innovators,” said Ed Macosky, Chief Product and Technology Officer at Boomi. “The contributions through this patent fundamentally challenge the existing paradigms inherent when constructing integration processes. Before this innovation, the construction of integration processes largely relied on the user's expertise and manual inputs using a drag and drop UI, which could be time-consuming and prone to errors, especially for those new to the platform. This AI-driven approach has transitioned construction of integration processes to an intelligent, predictive, and guided task.”
Boomi was also recently granted U.S. Patent No. 11,847,167, titled “System and Method for Generation of Chat Bot System with Integration Elements Augmenting Natural Language Processing and Native Business Rules.” This patent is for a technology solution built on the Boomi platform that creates a series of templatized processes and designs. This allows Boomi customers to build hybrid chatbots that combine rules-based connectivity, natural language processing, Boomi logic, and AI technologies to triage and route requests coming into the chatbot. This technology helped lay the foundation for Retrieval Augmented Generation and demonstrates Boomi’s early innovations in applying AI to integration.
Macosky added, “Achieving these patents reaffirms our commitment to continuous innovation and underscores our position as a leader in the industry. We are excited about the potential impact our AI patents will have for our customers and partners, and we look forward to continuing our mission of driving transformation through intelligent integration and automation.”
Additional Resources
- Learn more about the Boomi platform
- Explore the Boomiverse Community
- Follow Boomi on X (Twitter), LinkedIn, Facebook, and YouTube
About Boomi
Boomi powers the future of business with intelligent integration and automation. As a category-leading, global software as a service (SaaS) company, Boomi celebrates more than 20,000 global customers and a worldwide network of 800 partners. Organizations turn to Boomi’s award-winning platform to connect their applications, data, and people to accelerate digital transformation. For more information, visit boomi.com.
© 2024 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240131961796/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IFF Expands Innovation Center in Singapore with New Immersive Experience Hub10.7.2025 06:00:00 CEST | Press release
Immersive Hub to accelerate innovation, deepen customer collaboration and strengthen digital capabilities in Greater Asia IFF (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients, health and biosciences—today unveiled its new Immersive Experience Hub located within its Singapore Innovation Center. The multi-sensory facility enables IFF to work alongside customers to conceptualize, test, and refine product ideas in simulated real-world environments—enhancing decision-making, shortening development timelines and improving go-to-market success. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250709079831/en/ “The new space builds on IFF’s $30 million investment in Singapore in 2022, strengthening our position as a strategic innovation hub for Asia,” said Ramon Brentan, site leader of the IFF Singapore Innovation Center and vice president, regional general manager for Greater Asia, Scent. “The immersive space tran
Murata Begins World’s First Mass Production of 47μF Multilayer Ceramic Capacitor in 0402-inch Size10.7.2025 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has begun the world’s first mass production of the 0402-inch size (1.0 × 0.5 mm) multilayer ceramic capacitors (MLCC) with a capacitance of 47μF*. The new product line, available in two variants with different temperature characteristics, is designed to advance MLCC miniaturization and enhance customer system performance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250709615978/en/ [Murata Manufacturing Co., Ltd.] 47µF MLCC in 0402-inch Size In recent years, high-performance IT solutions, such as those used in AI servers and data centers, have seen rapid growth. Due to the often high component density demanded by these devices, optimized component placement within limited PCB areas is paramount. As a result, there is increasing demand for capacitors that offer both miniaturization and higher capacitance, along with high reliability under high-temperature co
Andersen Consulting udbygger sine kompetencer inden for cybersikkerhed10.7.2025 02:28:00 CEST | Pressemeddelelse
Andersen Consulting fortsætter med at udvikle sine konsulentydelser med samarbejdsfirmaet IT Security Consulting & Training, et rådgivningsfirma inden for informationssikkerhed med hovedkontor i Jordan. IT Security Consulting & Training blev stiftet i 2011 af administrerende partner Muntaser Bdair og har specialiseret sig i at betjene kunder i den statslige, finansielle og industrielle sektor med ekspertise inden for governance, risk og compliance (GRC), tekniske test, administrerede sikkerhedstjenester, databeskyttelse, cyberresiliens og bredere cybersikkerhedsinitiativer. IT Security Consulting & Training samarbejder med organisationer om at vurdere forretnings- og teknologitrusler, implementere robuste kontroller og opretholde overholdelsen af internationale sikkerhedsstandarder. "Vores mission er at give organisationer mulighed for at opnå det højeste niveau af informationssikkerhed gennem praktisk rådgivning, avanceret uddannelse og skræddersyede sikkerhedsløsninger," siger Muntas
Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development10.7.2025 02:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a global licensing agreement with BeOne Medicines Ltd., a global oncology company, for multiple fully human antibodies. Prior to this licensing agreement, BeOne Medicines had obtained a license to use Biocytogen’s RenMice® fully human antibody platform. Building on this established collaboration, the new agreement expands the partnership into antibody license, further strengthening the strategic relationship between the two companies. Dr. Yuelei Shen, President and CEO of Biocytogen, said, “BeOne Medicines is a global leader in drug development, and we are thrilled to enter into this strategic collaboration. The antibodies licensed under this agreement were discovered using our proprietary RenMice® fully human antibody platform, highlighting o
Andersen Consulting styrker sin tilstedeværelse inden for cybersikkerhed med 10Guards9.7.2025 23:28:00 CEST | Pressemeddelelse
Andersen Consulting udvider sin konsulentkapacitet gennem et samarbejde med 10Guards, en serviceorienteret virksomhed med base i Ukraine, som har specialiseret sig i at levere en bred vifte af professionelle tjenester uden at tilbyde produkter (det være software eller hardware). 10Guards blev stiftet i 2017 og tilbyder skræddersyede cybersikkerhedstjenester, herunder compliance audits, gap assessments og strategisk rådgivning med henblik på at styrke sikkerhedspositionen. De leverer også outsourcet cybersikkerhedssupport gennem virtuelle CISO'er og fulde virtuelle teams, optimering af sikkerhedsdriftscentre (SOC'er) for mere effektiv trusselsdetektering og -respons og etiske hackingtjenester som penetrationstest, social engineering-simuleringer og applikationssikkerhedsvurderinger på tværs af web-, mobil- og cloudmiljøer. "I dagens digitale miljø er cyberresiliens ikke et tilvalg – det er en forudsætning," siger Vitaliy Yakushev, administrerende direktør for 10Guards. "Vores mål er at
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom